EGR1 and breast cancer: To answer these key questions, we used Okadaic acid, an inducer of Egr-1 phosphorylation [62], to treat BC-3 and BCBL-1 cells, which enhanced Egr-1 phosphorylation in BC-3 and BCBL-1 cells (Figure 2A, a. and b, lane 4).